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HIV-1 Nef affects the trafficking of numerous cellular proteins to optimize viral replication and evade host defenses. The adaptor protein (AP)
complexes, which form part of the cytoplasmic coat of endosomal vesicles, are key cellular co-factors for Nef. Nef binds these complexes and alters
their physiologic cycle of attachment and release from membranes. Specifically, while AP-1 normally becomes cytosolic when attachment events
are blocked by inhibition of the GTPase cycle of ADP-ribosylation factor-1 (ARF1), the complex remains membrane-associated in Nef-expressing
cells. To investigate the mechanism of this effect, we used a permeabilized cell system to detect the de novo attachment of exogenous AP-1 to
endosomal membranes. Nef did not mediate de novo attachment independently of ARF1, despite its ability to maintain the association of AP-1 with
endosomal membranes when the activity of ARF1 was blocked. We conclude that Nef stabilizes AP complexes on endosomal membranes after
ARF1-dependent attachment. This stabilization may facilitate coat formation and stimulate the trafficking of multiple cellular proteins.
Published by Elsevier Inc.Keywords: HIV-1; Nef; AP-1; ARF1Introduction
The nef gene of HIV-1 is required for high-level viremia and
efficient pathogenesis in vivo (Deacon et al., 1995; Kestler et al.,
1991). This role in virulence is likely a consequence of directly
optimized viral replication and evasion of the host immune
response (Chowers et al., 1994; Collins et al., 1998). The
modulation of cellular protein trafficking underlies these effects.
For example, Nef causes the removal from the cell surface of CD4,
the primary receptor for HIV-1 (Garcia and Miller, 1991; Aiken et
al., 1994). This prevents the binding of the viral envelope
glycoprotein to CD4, which might otherwise impair the release
of virions from the plasma membrane and reduce the infectivity of
progeny virions (Lama et al., 1999; Ross et al., 1999). Nef also
interfereswith the presentation of viral antigens by down-regulating
class I and class IImajor histocompatibility complexes from the cell
surface, allowing viral evasion of the adaptive immune response
(Stumptner-Cuvelette et al., 2001; Schwartz et al., 1996).0042-6822/$ - see front matter. Published by Elsevier Inc.
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protein that interacts with members of a family of cellular
vesicle coat proteins called adaptor protein (AP) complexes
(Guy et al., 1987; Bresnahan et al., 1998). Four different AP
complexes have been identified, each potentially mediating
protein transport between distinct intracellular compartments
(Mellman, 1996; Boehm and Bonifacino, 2001; Hirst and
Robinson, 1998). AP-1 mediates transport between the
trans-Golgi network (TGN) and the endosomal/lysosomal
system, AP-2 between the plasma membrane and early/
sorting endosomes, AP-3 between the TGN or early
endosomes and late endosomes/lysosomes, and AP-4 be-
tween the TGN and basolateral plasma membranes. HIV-1
Nef demonstrably interacts with AP-1 and AP-3, and this
interaction requires a typical di-leucine-based sorting motif
within Nef (Bresnahan et al., 1998; Janvier et al., 2003).
In addition to simply interacting with AP complexes, Nef
alters the dynamic cycle of their attachment and release from
membranes (Janvier et al., 2003). The attachment and release
cycle of AP-1, AP-3, and AP-4 to membranes is regulated by the
GTPase cycle of ADP-ribosylation factor 1 (ARF1) and by the
phosphorylation status of the complex subunits (Ghosh and6) 148 – 155
www.e
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1997; Ooi et al., 1998; Traub et al., 1993). The GTPase cycle of
ARF1 regulates attachment. Guanine nucleotide exchange
factors (GEFs) displace GDP from cytosolic ARF1 and replace
it with GTP, inducing a myristoyl switch mechanism that
exposes the N-terminus of the protein and allows its association
with TGN and endosomal membranes (Donaldson and Klaus-
ner, 1994; Stamnes and Rothman, 1993; Goldberg, 1998).
Membrane-associated ARF1-GTP induces a transient, high-
affinity docking site for theAP complexes (Zhu et al., 1998). The
mechanism of the formation of this docking site and its
composition are uncertain. The site may include phosphoinosi-
tides, in particular phosphoinositol 4,5-bisphosphate (PIP2) and/
or phosphoinositol 4-phosphate [PI(4)P], which are required for
the membrane-association of AP-1 (Crottet et al., 2002; Wang et
al., 2003). However, GTP-bound ARF1 can also bind the AP-1
(and AP-4) complex directly, suggesting that ARF1 itself may
comprise the docking site (Austin et al., 2000; Boehm et al.,
2001). Once the AP complexes are recruited from the cytosol to
this membrane-docking site, binding to the sorting signals of
transmembrane cargo proteins further stabilizes their association
with membranes (Zhu et al., 1998). GTPase-activating proteins
(ARF1-GAPs) rapidly induce the hydrolysis of GTP to GDP,
allowing the myristoyl group to fold back onto ARF1 and
releasing ARF1 to the cytosol (Boehm et al., 2001; Goldberg,
1999). Consequently, ARF1 is not a stoichiometric component
of vesicles containing AP complexes, but rather seems to
perform a catalytic function in initiating coat assembly (Zhu et
al., 1998). Phosphorylation of AP complex subunits regulates
both the attachment and release of AP complexes from
membranes (Ghosh and Kornfeld, 2003). Dephosphorylation
of the h subunit of AP-1 is associated with recruitment of AP-1
to membranes, and phosphorylation of the A1 subunit increases
the affinity of AP-1 complexes for tyrosine-based sorting signals
in transmembrane proteins. In contrast, dephosphorylation of A1
induces the release of AP-1 from membranes. This release is
presumably a prerequisite for the fusion of transport vesicles
with target membranes.
Under physiologic conditions, AP complexes undergo a rapid
cycle of membrane attachment and release (Stamnes and Roth-
man, 1993; Simpson et al., 1997; Ooi et al., 1998; Traub et al.,
1993). The cellular pools of AP-1 and AP-3 become diffusely
cytosolic within 2 to 5 min after cells are treated with brefeldin A
(BFA), a fungal metabolite that blocks new attachment events by
inhibiting ARF1 GEFs (Helms and Rothman, 1992).
In contrast, in cells that express Nef, AP-1 and AP-3 remain
bound to juxtanuclear, endosomal membranes for up to 30 min
after new attachment events are blocked by BFA (Janvier et al.,
2003). This effect is most robust when Nef is expressed as the
cytoplasmic domain of a transmembrane protein, such as CD8,
which likely reflects the complete membrane-association of
such chimeras. The membranes on which Nef stabilizes these
complexes have not been identified unambiguously, but they
are likely derived at least in part from perinuclear recycling
endosomes, a compartment in which Nef resides and whose
morphology Nef distorts (Madrid et al., 2005). Nef also
induces an abnormally persistent association of AP-1 andAP-3 with endosomal membranes in cells that express
dominant-negative ARF1 (which sequesters ARF1 GEFs)
or that over-express ARFGAP-1 (Janvier et al., 2003).
Biochemically, Nef does not appear to have ARF1-like or
ARF1-GEF-like activity in vitro, either of which could have
explained these effects (Janvier et al., 2003). Furthermore,
Nef neither stimulates ARF1-GEFs nor inhibits ARFGAP-1
(Janvier et al., 2003). Although ARF1 has been reported to
bind directly to Nef (Faure et al., 2004), it is not recruited to the
sites of Nef-mediated endosomal association of AP-1 in BFA-
treated cells, suggesting that Nef does not mediate the
association of AP complexes with membranes via ARF1
(Janvier et al., 2003). Instead, the persistent attachment of the
complexes to endosomal membranes requires the leucine-based
sorting signal in Nef, indicating that direct binding to AP-1 and
AP-3 is likely key to this activity (Janvier et al., 2003).
Two mechanisms could account for the persistent mem-
brane-attachment of AP-1 and AP-3 induced by Nef in BFA-
treated cells: (1) Nef could induce a high-affinity binding site
for the AP-1 and AP-3 complexes independently of ARF1;
and/or (2) Nef could stabilize the complexes on membranes by
blocking their release. To determine if Nef mediates ARF1-
independent attachment, we used a system that detects the de
novo attachment of exogenously added AP complexes to the
membranes of permeabilized cells (Robinson and Kreis, 1992).
The results suggest that Nef does not mediate new attachment
events independently of ARF1. We present a model in which
Nef stabilizes the vesicle coat by inhibiting the release of AP
complexes, leading to the increased inclusion of proteins such
as CD4 in endosomal vesicles.
Results and discussion
GTP-locked ARF1 and Nef each induce the persistent
attachment of AP-1 to endosomal membranes in brefeldin A
(BFA)-treated hamster cells
To determine the mechanism by which Nef mediates the
association of AP complexes with endosomal membranes, we
modified a microscopic assay that detects the attachment of
exogenously added AP complexes to the membranes of
permeabilized target cells (Robinson and Kreis, 1992). In this
assay, a species-specific antibody that recognizes only the
exogenously added complexes is used, so that the endogenous
complexes in the target cells are not detected. We used baby
hamster kidney (BHK) cells as target cells and HL-60 human
monocytoid cells as the source of the exogenous AP complexes.
To ensure that this systemwas permissive for Nef-activity, we
first determined whether BHK cells supported the Nef-mediated
association of endogenous AP-1 with endosomal membranes.
BHK-21 cells were transfected to transiently express either
constitutively active (GTP-locked) ARF1 [ARF1-Q71L, which
is defective for GTP hydrolysis, tagged with an influenza
hemagglutinin (HA) epitope] or Nef as the cytoplasmic domain
of a chimera containing the luminal and transmembrane portions
of the CD8 a chain (CD8-Nef). The cells were treated with BFA
for 5 min, fixed, immunostained for hamster g-adaptin (AP-1)
Fig. 1. ARF1-Q71L and Nef induce the persistent association of AP-1 with endosomal membranes in BFA-treated hamster cells. BHK-21 cells were transfected with
HA-ARF1-Q71L or CD8-Nef. 24 h later, the cells were treated with BFA (10 Ag/ml) for 5 min, fixed, and immunostained for hamster g-adaptin (AP-1) and for HA
or CD8. Insets show a portion of the image at higher magnification. Green: ARF Q71L or CD8-Nef; red: hamster AP-1. Each image is a single optical section
acquired using a laser scanning confocal microscope.
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immunofluorescence microscopy (Fig. 1). Both constitutively
active ARF1 and Nef caused the endogenous AP-1 in BHK cells
to remain membrane-associated despite the inhibition of ARF1-
GEFs by BFA. AP-1 often co-localized with Nef on large,
perinuclear vesicles. In contrast, the AP-1 in ARF1Q71L- or
Nef-negative cells was uniformly dispersed throughout the
cytosol by treatment with BFA.ACD8-Nef chimera inwhich the
leucines of the Nef ExxxLL motif were replaced with alanines
did not stabilize AP-1 on the endosomal membranes of BFA-
treated BHK-21 cells, as described previously in HeLa cells
(data not shown; Janvier et al., 2003). These data indicated that
hamster cells support the effects of Nef on the dynamics of AP
complexes as first described in human cells (Janvier et al., 2003).
Exogenous human AP-1 attaches to the internal membranes of
permeabilized BHK cells
Next, we determined whether exogenous human AP-1
complexes would attach to the internal membranes of permea-Fig. 2. The de novo attachment of exogenous human AP-1 to the internal mem
permeabilized with digitonin, exposed to either buffer (a) or cytosol from human H
treated with BFA (10 Ag/ml) for 5 min before permeabilization, and BFA (10 Ag/m
cytosol. The images are single optical sections acquired using a laser scanning conbilized BHK cells. Human cytosol was prepared from HL-60
cells by freeze-thaw lysis and dounce homogenization followed
by high-speed centrifugation. BHK-21 cells were permeabilized
with digitonin in a potassium-based buffer. Then, HL-60
cytosol, supplemented with 1 mM GTP, 1 mM ATP, and an
ATP-regeneration system consisting of creatine-phosphate and
creatine phosphokinase was added and the cells were incubated
for 5 min at 37 -C. The cells were washed once, fixed,
immunostained with an antibody that recognizes human but
not hamster g-adaptin (AP-1), and visualized by confocal
immunofluorescence microscopy (Fig. 2). In the absence of
exogenous human cytosol, no staining was evident (panel a).
When human cytosol was added, over 80% of the cells stained in
a punctate, juxtanuclear, or perinuclear pattern consistent with
the attachment of the exogenous complexes to endosomal
membranes (panel b). This de novo attachment required the
supplemental ATP noted above (data not shown). When the cells
were treated with BFA for 5 min prior to permeabilization and
when BFA was added to the human cytosol, the de novo
attachment of the exogenous AP-1 was inhibited (panel c).branes of permeabilized BHK cells is sensitive to BFA. BHK-21 cells were
L-60 cells (b), fixed, and stained for human g-adaptin. Cells in panel c were
l) was included during the permeabilization and incubation of the cells with
focal microscope.
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can bemonitored using permeabilized BHK cells and exogenous
human adaptors from the cytosol of HL-60 cells; the results also
indicated that these attachment events are sensitive to the
inhibition of ARF1-GEFs by BFA.
ARF1-Q71L mediates the de novo attachment of exogenous
human AP-1 to the internal membranes of permeabilized,
BFA-treated BHK cells; Nef does not
To determine whether Nef-mediated the ARF1-independent
de novo attachment of AP-1, BHK-21 cells were transfected to
transiently express HA-ARF1-Q71L or CD8-Nef, treated with
BFA, permeabilized with digitonin, exposed to supplemented
human cytosol as described above but including BFA, fixed,
immunostained for human g-adaptin and HA-ARF1 or CD8-
Nef, and visualized by confocal immunofluorescence micros-
copy (Fig. 3). The GTP-locked ARF1-Q71L induced the
attachment of human AP-1 to the internal membranes of the
BHK cells despite the inhibition of ARF1-GEFs by BFA. In
contrast, CD8-Nef did not induce the attachment of human AP-
1 to the internal membranes of the BFA-treated BHK cells.
These results suggested that the de novo attachment of AP-1 to
endosomal membranes is dependent on ARF1 even in Nef-
expressing cells.
In the absence of BFA, exogenous human AP-1 attaches to the
endosomal membranes of permeabilized BHK cells exclusively
at sites distinct from Nef
The preceding data suggested that although Nef mediates a
persistent association of AP-1 with the endosomal membranes
of BFA-treated BHK cells (Fig. 1), it is unable to mediate
ARF1-independent attachment events (Fig. 3). These results
are consistent with the hypothesis that Nef alters AP complexFig. 3. ARF1-Q71L but not Nef induces the de novo attachment of exogenous human
BFA. BHK-21 cells were transfected with HA-ARF1-Q71L or CD8-Nef. 24 h lat
exposed to cytosol from human HL-60 cells containing BFA (10 Ag/ml), fixed, and
red: human AP-1. The images are single optical sections acquired using a laser scadynamics by inhibiting the release of the complexes from
endosomal membranes.
To further test this hypothesis, de novo attachment experi-
ments using BHK cells expressing ARF1-Q71L or CD8-Nef
were repeated in the absence of BFA (Fig. 4). We reasoned that
if Nef inhibits the release of AP-1 from membranes by directly
binding to the complex, then the binding sites on Nef might be
saturated with endogenous hamster AP complexes and
consequently would be unavailable to bind exogenous human
AP-1. As in the experiment shown in Fig. 2, most of the
permeabilized BHK cells shown in Fig. 4 took up exogenous
human AP-1. However, while much of the newly attached AP-
1 co-localized with ARF1-Q71L, almost none co-localized
with CD8-Nef. This exclusion of de novo attached human AP-
1 from the sites of CD8-Nef is consistent with saturation of Nef
with the endogenous, hamster AP complexes and a low rate of
exchange with the exogenous, human complexes.
Native Nef as expressed from the HIV-1 genome stabilizes the
association of AP-1 with endosomal membranes
The above experiments were performed using CD8-Nef to
optimize the association of Nef with membranes and maximize
the stabilization effect. To document that the stabilization of
AP complexes on membranes is not wholly an artifact of the
use of the CD8-Nef chimera, we expressed native Nef from the
complete viral genome by transfecting BHK-21 cells with a
proviral plasmid, pNL4-3. To detect Nef, we used a sheep
antiserum for indirect immunofluorescence (Fig. 5). Cells that
were not transfected showed complete dispersal of AP-1
throughout the cytosol following 5 min of treatment with
BFA (compare panels a and b, Fig. 5). In contrast, in
approximately half of the cells expressing Nef, AP-1 remained
concentrated in a juxtanuclear region, consistent with persistent
association with endosomes (panels c and d, Fig. 5). These dataAP-1 to the internal membranes of permeabilized BHK cells in the presence of
er, the cells were treated with BFA (10 Ag/ml), permeabilized with digitonin,
stained for human g-adaptin and HA or CD8. Green: ARF Q71L or CD8-Nef;
nning confocal microscope.
Fig. 4. In the absence of BFA, exogenous human AP-1 attaches to the internal membranes of permeabilized BHK cells at sites co-incident with ARF1-Q71L but not
co-incident with Nef. BHK-21 cells were transfected with HA-ARF1-Q71L or CD8-Nef. 24 h later, the cells were permeabilized with digitonin, exposed to cytosol
from human HL-60 cells, fixed, and stained for human g-adaptin and HA or CD8. Insets show a portion of the image at higher magnification. Green: ARF Q71L or
CD8-Nef; red: human AP-1. The images are single optical sections acquired using a laser scanning confocal microscope.
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Nef is detectable with native Nef as expressed by the viral
genome.
In summary, we investigated whether the Nef-mediated
stabilization of AP-1 on endosomal membranes as revealed in
BFA-treated cells is due to an ARF1-independent attachment
process. Using a permeabilized cell system in which the de
novo recruitment of exogenous AP-1 to endosomal membranesFig. 5. Native Nef expressed from the viral genome stabilizes the association of
(a and b) or transfected with complete viral DNA (pNL4-3; c and d). Twenty-four
for 5 min (b–d) before fixation and staining for endogenous hamster AP-1 (a, b, d
and d are images of the same field, in which Nef is green (c) and AP-1 is red (d)
spinning disc confocal microscope and processed using ‘‘no-neighbors’’ deconvolwas visualized microscopically, we observed that Nef was
unable to mediate ARF1-independent attachment events. These
events appear to require ARF1 even in Nef-expressing cells.
Furthermore, when ARF1-mediated attachment was not
blocked, newly recruited exogenous AP-1 was excluded from
sites occupied by Nef. This exclusion suggested that Nef was
saturated with endogenous AP complexes and that the turnover
rate of the complexes on Nef was significantly longer than theAP-1 with endosomal membranes. BHK-21 cells were either not transfected
hours later, the cells were either untreated (a) or treated with BFA (10 Ag/ml)
) and for Nef (c). Panels a and b are images of different preparations; panels c
. Each image is a projection of a Z-series of optical sections acquired using a
ution (SlideBook software; Intelligent Imaging Innovations).
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ARF1 mutant, ARF1-Q71L, showed no evidence of saturation
and was able to recruit exogenous AP-1 whether or not the
GTPase cycle of native ARF1 was blocked.
These data demonstrate that Nef cannot be viewed
mechanistically as a constitutively active viral version of
ARF1. The ability of ARF1-Q71L to recruit exogenous
complexes suggests an activity that generates high affinity
docking sites in non-saturable numbers, perhaps based on
changes in membrane phospholipids (Crottet et al., 2002; Wang
et al., 2003). In contrast, the inability of Nef to recruit
exogenous complexes is consistent with a direct binding
mechanism that is saturable by the endogenous complexes.
We cannot exclude that Nef could induce ARF1-independent
de novo attachment in the absence of saturating endogenous
complexes. Such an effect might be demonstrable using donor
cytosol from Nef-expressing cells or by adding purified
myristoylated Nef to the donor cytosol during the de novo
attachment experiments. Nevertheless, the data indicate that
ARF1-independent attachment is not required for the observed
altered dynamics of the complexes: when the GTPase cycle of
ARF1 is blocked, new attachment events at sites containing
Nef are not observed (Fig. 3), yet the membrane-association of
endogenous complexes is stabilized (Fig. 1). Furthermore, the
apparent low turnover rate of AP-1 on Nef (Fig. 4) implies that
the release of the endogenous AP complexes from endosomal
membranes has been inhibited. The release of AP complexes
from membranes is regulated at least in part by dephosphor-
ylation (Ghosh and Kornfeld, 2003). Although Nef might
inhibit dephosphorylation events involved in complex release,
we favor the hypothesis that the well documented direct
binding between Nef and AP-1 (and AP-3) is the basis for the
inhibition of the release of the complexes (Bresnahan et al.,
1998; Janvier et al., 2003). This hypothesis is supported by the
observation that the residues required for the stabilization effect
are either within or flanking the C-terminal loop of Nef, whichFig. 6. Model in which Nef stabilizes the vesicle coat and enhances the trafficking
insufficient for the stabilization of the AP coat and the formation of transport vesicles
to incorporate into vesicles, whose formation is also enhanced.contains a canonical leucine-based AP-binding motif (Janvier
et al., 2003; Coleman et al., 2005).
How might post-attachment stabilization of AP complexes
contribute to the ability of Nef to affect the trafficking of
multiple cellular transmembrane proteins? To answer this, it is
important to note that the formation of transport vesicles
appears to be a process regulated by the rapid association and
disassociation of coat components. Furthermore, many coat
association-events are abortive and do not lead to the formation
of a vesicle (Ehrlich et al., 2004). If Nef stabilizes AP
complexes post-attachment, then nascent coats may be more
likely to persist and allow the formation of transport vesicles.
This model is in a broad sense consistent with the increased
formation of clathrin coated pits observed along the plasma
membrane of Nef-expressing cells (Foti et al., 1997), although
the specific AP complex in that case is presumably AP-2. In
addition to increased vesicle-formation, prolonged membrane-
association of the AP complexes might allow more efficient
inclusion of transmembrane proteins into the vesicles, espe-
cially those with relatively weak AP-binding signals or those
that are present at relatively low concentrations. These
considerations suggest a model in which Nef stabilizes AP
complexes on membranes post-attachment, facilitating the
interaction of modulated proteins with the complexes and
enhancing their inclusion in transport vesicles (Fig. 6). These
effects would be expected to cause alterations in the trafficking
of numerous cellular proteins by Nef, as has now been well
documented.
Materials and methods
Antibodies
The following antibodies were used: murine anti-g adaptin
clone 88 (BD Biosciences) to recognize rodent g adaptin,
murine anti-g adaptin clone 100/3 (Sigma) to recognize humanof cellular proteins. Top: in the absence of Nef, a target protein such as CD4 is
; bottom: Nef stabilizes the AP coats, allowing low affinity targets such as CD4
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(Jackson Laboratories), murine FITC-conjugated antihemag-
glutinin (Covance), a sheep antiserum raised to recombinant
HIV-1 NefNL4-3 (Pandori et al., 1996), rhodamine X-conjugated
goat anti-mouse IgG (Jackson Laboratories), and rhodamine X-
conjugated donkey anti-sheep IgG (Jackson Laboratories).
HL-60 cytosol preparation
HL-60, human promyelocytic leukemia cells (5  108;
ATCC #CCL-240), were pelleted by centrifugation, resus-
pended in an equal volume of cytosol buffer (25 mM HEPES,
125 mM potassium acetate, 2.5 mM magnesium acetate, 1 mg/
ml glucose, pH 7.0), zap frozen by exposure to liquid
nitrogen, thawed, and then dounce homogenized. The dis-
rupted cells were then centrifuged at 100,000  g for 1 h. The
supernatant was collected, frozen using liquid nitrogen, and
stored at 80 -C until used. Protein concentration ranged
between 10 and 15 mg/ml.
Nef-mediated membrane-association of adaptor complexes in
living cells
Hamster kidney cells, BHK-21 (C-13; ATCC #CCL-10),
were transfected with plasmids expressing either HA-ARF1
Q71L (Peters et al., 1995), CD8-Nef (Erdtmann et al., 2000), or
the complete HIV-1 genome (pNL4-3; Adachi et al., 1986)
using FuGene 6 (Roche). After 24 h, the cells were treated with
10 Ag/ml brefeldin A (Epicentre) for 5 min, then fixed with 3%
paraformaldehyde and permeabilized with 0.1% NP-40. To
stain AP-1 in cells expressing HA-ARF1 Q71L or CD8-Nef,
the preparations were incubated with murine anti-g-adaptin
(clone 88), then with Rhodamine X-conjugated goat anti-
mouse IgG. After extensive washing to remove unbound
secondary antibody, the cells were incubated with normal
mouse serum to block exposed antigen binding sites on the
bound goat anti-mouse IgG secondary antibody, then stained
with FITC-conjugated anti-HA or FITC-conjugated anti-CD8.
The cells were then analyzed using a laser scanning, confocal
fluorescence microscope (BioRad Radiance). To stain AP-1 in
cells expressing native Nef from the NL4-3 genome, the
preparations were first incubated simultaneously with murine
anti-g-adaptin (clone 88) along with a sheep antiserum raised
to Nef, then with Rhodamine X-conjugated donkey anti-mouse
IgG along with FITC-conjugated donkey anti-sheep IgG. These
cells were analyzed using a spinning disc confocal microscope
(Olympus).
De novo recruitment of AP-1 to membranes of permeabilized
cells
BHK-21 cells (4  104) were plated on 3-well ICN slides
24 h before transfection with either HA-ARF1 Q71L or CD8-
Nef constructs using FuGene 6 (Roche). After 24 h, the cells
were washed with cytosol buffer (see above), then permeabi-
lized with 40 Ag/ml digitonin (Sigma) in cytosol buffer at 4 -C
for 10 min, and again washed with cytosol buffer. HL-60cytosol supplemented with 1 mM ATP, 1 mM GTP, 16 mM
phosphocreatine (Sigma), and 0.1 mg/ml creatine kinase
(Roche) was added and the permeabilized cells were incubated
at 37 -C for 5 min. The cells were washed with cytosol buffer
and then fixed with 3% paraformaldehyde in cytosol buffer for
1 h at room temperature. The cells were washed with cytosol
buffer and then re-permeabilized with 0.1% NP40 in cytosol
buffer. Immunostaining was conducted as described above
except that murine anti-g adaptin clone 100/3 was used as the
primary antibody to recognize only human g-adaptin, and the
cells were analyzed by laser scanning, confocal microscopy.
To block de novo attachment of AP-1 mediated by endoge-
nous ARF1, the cells were treated with 10 Ag/ml brefeldin A
(Epicentre) for 5 min at 37 -C just before the initial
permeabilization, and 10 Ag/ml BFA was included at each
subsequent step of the procedure until aldehyde-fixation.Acknowledgments
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